Venture Capital

With veteran leader Brian McKelligon at the helm, Infinity Bio aims to commercialize its powerful MIPSA platform and redefine precision medicine.

China is rolling out a 10-day visa-free transit policy and promoting immersive cultural tours. But can it overcome geopolitical headwinds to revive tourism?

The controversial safety app Citizen is in 15 new cities. It promises real-time alerts but brings a history of privacy concerns and vigilantism fears.

With a massive $68.7M seed round and novel T-cell engager tech, Shanghai's Excalipoint is pioneering a new model for rapid drug development.

Operator of China's BOSS Zhipin announces a major dividend and buyback plan, signaling deep confidence in its market dominance and future profitability.

With a new context-aware AI and $45M from General Catalyst, the PowerPoint rival aims to automate design and conquer the global presentation market.

With a new CEO and Chair, IsomAb is advancing a disease-modifying drug for 9 million angina patients, eyeing a major Series A fundraise.

The strategic divestment to Blue Moon Metals highlights Liberty Gold's pivot to its core gold assets and a broader mining trend of portfolio specialization.

A new collaboration will use innovative protein binders to fight animal disease, bolstering global food security and public health under the One Health framework.

Student innovators unveil an AI lifeline for ICUs at Quest Global's Ingenium, tackling a critical medical crisis and showcasing India's engineering future.

Shenzhen's CIBF 2026 will unveil next-gen sodium-ion and solid-state batteries, highlighting China's soaring exports amid rising global competition.

A novel drug mimicking exercise aims to solve a major problem with today's weight-loss meds: muscle loss. Atrogi's ATR-258 has entered a key human trial.

The social media giant posts a 70% overseas revenue jump, but a sharp decline in paying users for its core apps Momo and Tantan paints a complex picture.

A key investment in a massive French synthetic fuel plant aims to tackle aviation emissions, driven by EU mandates and advanced carbon capture technology.

A new university-industry partnership aims to solve the key challenges of orbital computing, validating early bets on the future of decentralized AI.

From Hong Kong to the world, Winson Siu's rigorous online teaching method is transforming student outcomes and building a multi-million dollar business.

The NYC health giant is using an AI platform to find millions in savings, aiming to reinvest the money back into patient care and infrastructure.

With $7M from True Ventures, a Thiel Fellow's startup is building AI 'ops agents' to help America's small factories finally compete on a global scale.

Dave Asprey’s 2026 BEYOND conference adds star power and a focus on consciousness, but how much is science versus high-tech hype?

A new venture from Mythical Games alumni is using agentic AI to transform sports viewing into an interactive game, starting with ONE Championship.